-
Founder, Haight Ashbury Free Clinics, San Francisco, California
-
Chief of Addiction Medicine, Bayside Marin, San Rafael, California
-
Medical Director, Center Point, San Rafael, California
-
Adjunct Professor, University of California, San Francisco
-
Former Executive Medical Director, Prometa Center, San Francisco, California
-
Former Medical Director, California State Department of Alcohol and Drug
Programs
-
Fellow and Past President, American Society of Addiction Medicine
-
Areas of Specialization: Addiction Medicine and Clinical Toxicology
Dr. Smith founded the Haight Ashbury Free Clinics in June of 1967. He works with
impaired health professionals in his private practice, David E. Smith, MD &
Associates, in San Francisco. He is Former Executive Medical Director of the
Prometa Center, in Santa Monica, California and is a past President of the
American Society of Addiction Medicine (ASAM) and of the California Society of
Addiction Medicine (CSAM). Dr. Smith is the Founder and Executive Editor of the
Journal of Psychoactive Drugs.
Dr. Smith is recognized as a national leader in the areas of the treatment of
addictive disease, the psychopharmacology of drugs, new research strategies in
the management of drug abuse problems, and appropriate prescribing practices for
physicians. He lectures on the management, legal implications and repercussions
of dependence on psychoactive drugs, including cocaine, alcohol and prescription
drugs. He also speaks on the subjects of impaired and recovering physicians,
substance abuse in the workplace and dual diagnosis disorders.
He teaches that addiction is a primary medical illness which is best treated in
a multidisciplinary integrated fashion with an abstinence-oriented model of
recovery utilizing the group process and the 12-Step programs of Alcoholics
Anonymous, Narcotics Anonymous and Cocaine Anonymous as central to the process
of recovery.
RECENT PROJECTS
Title: State Medical
Director on Substance Abuse
Project Period: 10/1/05-6/30/06
Funding Agencyies: Department of Alcohol and Drug Programs (ADP), State
of California
Description: Dr. Smith serves as the State Medical Director on Substance
Abuse Services, providing clinical consultation and direction regarding public
health quality assurance, training on an effective provision of substance
treatment, as well as other aspects of the alcohol and other drug continuum of
care, primary medical care, and infection control.
Title: Substance Abuse
Prevention and Treatment (SAPT)
Project Period: 7/1/98-6/30/05
Funding Agencies: Department of Health Alcohol and Drug Program, State of
California (ADP)
Description: Dr. Smith and his staff work in consultation with the ADP
Department Executive Staff to provide review and consultation to assist in (1)
the development and review of a post-service/post-payment utilization review of
Short-Doyle Drug/Medi-Cal services, (2) the development of a managed system of
care for substance abuse services, (3) collaboration with the Dept. of Health
Services, the review of protocols, standards, and regulations designed to
effectively control the spread of infectious disease, and (3) addressing other
state health policies and issues.
Title: Alcohol and Drug
Program (ADP) Substance Abuse Program Treatment
Project Period: 7/1/00-6/30/03
Funding Agencies: Department of Health Alcohol and Drug Program, State of
California
Description: To provide clinical consultation and direction regarding
effective substance abuse treatment, primary medical care and infection control,
and public health quality assurance.
Title: Technical
Assistance to Department of Health, Alcohol and Drug Program (ADP)
Project Period: 7/1/98-6/30/00
Funding Agencies: Department of Health, Alcohol and Drug Program, State
of California
Description: Dr. Smith provided AOD prevention technical assistance to
counties and local AOD prevention programs, as well as ADP. These services
included helping counties and providers (1) understand how to use PAD and data
that can be locally acquired to identify, assess, and prioritize local AOD
prevention needs on a sustained basis; (2) select and deliver practical, proven
and relevant prevention actions; and (3) Measure outcomes and the use of results
to refine and improve AOD prevention.
PUBLICATIONS (Since 1985)
Journals
Ling, W, Wesson, DR, Smith,
DE. Prescription Opiate Abuse. Substance Abuse: A Comprehensive Textbook,
Lowinson, JH, Ruiz, P, Millman, RB, Langrod, JG, eds. pp. 459-468, Lippincott,
Williams & Wilkins, 2005.
Smith, DE, Glatt, W, Tucker,
DE, Deutsch, R, Seymour, R. Drug Testing in the Workplace: Integrating Medical
Review Officer Duties into Occupational Medicine. Occupational Medicine: State
of the Art Reviews, Volume 17(1), pp. 79-90, January-March 2002.
Ling, W & Smith, DE.
Buprenorphine: blending practice and research. Journal of Substance Abuse
Treatment, Volume 23(2002), pp. 87-92.
Smith DE & Wesson DR.
Benzodiazepine and Other Sedative-Hypnotic Dependence. Textbook of Substance
Abuse Treatment, Second Edition. Galanter, M & Kleber, HD, eds., American
Psychiatric Press, pp. 239–250, 1999.
Smith, DE & Seymour, RB.
Overcoming Cultural Points of Resistance to Spirituality in the Practice of
Addiction Medicine. Addiction and Spirituality: A multidsciplinary Approach.
Morgan, OJ, & Jornan, M., eds., pp. 95–109, Chalice Press, 1999.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 6(1), January-February, 1999, p.7.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 6(2), March-April, 1999, p. 7.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 6(3), May-June 1999, p. 7.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 6(4), July-August, 1999, p. 7.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 6(5), September-October, 1999, p.7.
Smith, D & Heilig, S.
“Medicalizing” American Drug Policy—A Much-Needed Focus on Prevention &
Treatment. San Francisco Medicine, Volume 72 (10), pp. 28–30,
November/December, 1999.
Seymour, RB & Smith, DE.
Psychological and Psychiatric Consequences of Hallucinogens. Handbook of
Substance Abuse: Neurobehavioral Pharmacology. RE Tarter, RT Ammerman & PJ Ott,
eds., pp. 241–251, Plenum Press, 1998.
Wesson, D, Smith, DE, Ling,
W. Pharmacologic Therapies for Benzodiazepine and other sedative-hypnotic
addiction. Principles of Addiction Medicine, second ed. 517-530, 1998.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 5(1), January-February, 1998.
Smith, DE & Seymour, RB.
International Addictions Infoline. Journal of Psychoactive Drugs. Volume 30 (1),
pp. 111-117, January-March, 1998.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 5(2), March-April, 1998.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 5(3), May-June, 1998.
Smith, DE. Review of the AMA
Council on Scientific Affairs Report on Medical Marijuana. Journal of
Psychoactive Drugs. Volume 30(2), pp. 127-136, April-June, 1998.
Calhoun, SR, Galloway, G &
Smith, DE. Abuse Potential of Dronabinol (Marinol®). Journal of Psychoactive
Drugs. Volume 30(2), pp. 187-196, April-June, 1998.
Smith, DE, Ehrlich, P &
Seymour, R. Current Trends in Adolescent Drug Use. San Francisco Medicine.
Volume 71(5), pp. 22-23, 26, June, 1998.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 5(4), July-August-June, 1998.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 5(5), September-October, 1998.
Smith DE & Heilig, S, Editors.
Marijuana at The Millenium: Medical and Social Implications. Journal of
Psychoactive Drugs, Volume 30(2), 1998.
Smith DE, Galloway GP,
Frederick SL, Staggers FE, Gonzalez M, Stalcup SA. 1997. Gammahydroxybutyrate:
An Emerging Drug of Abuse that Causes Physicial Dependence. Addiction. Volume
92(1), pp. 89-96.
Smith DE & Seymour, RB.
Benzodiazepine: Disintossicazione. Medicine delle Tossicodipendenze (Italian
Journal of the Addictions). Vol. 5, 1-2, 1997.
Smith DE & Miller NS. The
Integration of Pharmacotherapy and Nonpharmacotherapy. Journal of Addiction
Diseases. Volume 16, pp. 51-64, Number 4, 1997.
Smith DE & Seymour RB.
Addiction Medicine and the Free Clinic Movement. Journal of Psychoactive Drugs.
Volume 29, pp. 155-160, April-June, 1997.
Smith DE & Seymour RB. The
Many Meaning of Free. Humanism in the Health Sciences. Volume 2, pp. 6-7, Fall,
1997.
Smith, DE & Seymour RB. Ask
Dr. Dave. New Times. Volume 4(6), November-December, 1997.
Seymour, RB, Smith DE.
Treatment of Protracted Drug-Induced Syndromes. In Norman S. Miller, MD, ed. The
Principles and Practice of Addictions in Psychiatry. W.B. Saunders Company,
Philadelphia, 1997.
Dupont, RL, Smith, DE,
Deutsch, R, Clark, HW, Editors. Drugs, Crime & Violence. Journal of Psychoactive
Drugs, Volume 29(4), 1997.
Smith, DE & Seymour, RB.
Cannabis and Cannabis Withdrawal. Journal of Substance Misuse, 2(1), 1997.
Smith, DE, Galloway, GP &
Seymour, RB. Methamphetamine Abuse and Treatment. Valparaiso University Law
Review, 1997.
Seymour, RB & Smith, DE.
Benzodiazepine Use and Misuse. Medicina delle Tossicodipendenze (The Italian
Drug Abuse Journal), 1997.
Smith DE, Galloway GP,
Newmeyer J, Knapp T, Stalcup SA. A Controlled Trial of Imipramine for the
Treatment of Methamphetamine Dependence. Journal of Substance Abuse Treatment,
Vol. 13, pp. 493-497, November, 1996.
Smith DE, Miller NS & Gold MS.
Manual of Therapeutics for Addictions. John Wiley & Sons, Inc.,1997.
Smith DE, Galloway GP, Seymour
RB. Methamphetamine: An Old Problem Returns. American Society of Addiction
Medicine News. 11(1): 6-7, 1996.
Smith DE, Frederick SL,
Galloway GP, Staggers FE, Stalcup SA. Gammahydroxybutyrate: A Putative
Neurotransmitter That is Abused and Causes Physical Dependence. in Harris, LS
(ed): Problems of Drug Dependence, 1994: Proceedings of the 56th Annual
Scientific Meeting, The College on Problems of
Drug Dependence, Inc.
Rockville, MD. National Institute on Drug Abuse, 1996.
Smith DE. The 1995
Distinguished Lecturer in Substance Abuse. Journal of Substance Abuse Treatment.
Vol. 13(4), pp. 289-294, 1996.
Smith, DE & Seymour, RB.
Advances in Anticaving Agents: Adjunctive Use of Medication Continues as Relapse
Prevention Strategy. Employee Assistance, 8(4), 1996
Smith, DE, Lawlor B, &
Seymour, RB. Health Care at the Crossroads. San Francisco Medicine, 69(6), 1996.
Smith DE, Calhoun SR, Galloway
GP, Wesson DR. 1996. Abuse of Flunitrezepam (Rohypnol) and other Benzodiazepines
in Austin and Southeast Texas. Journal of Psychoactive Drugs, 28(2).
Smith DE & Wesson DR.
Benzodiazepine and Other Sedative-Hypnotic Dependence. Treatment of Psychiatric
Disorders, Second Edition, American Psychiatric Press, Volume 1, pp. 673-683,
1995.
Smith DE, Wesson DR & Calhoun
SR. Rohypnol: Quaalude of the Nineties? CSAM News, Summer 1995, Volume 22, No.
2.
Wesson DR & Smith DE.
Benzodiazepines and Other Sedative-Hypnotics. Textbook of Substance Abuse
Treatment. The American Psychiatric Press, pp. 179-190, 1994.
Smith DE. AA Recovery and
Spirituality: An Addiction Medicine Perspective; Response Paper. Journal of
Substance Abuse Treatment, Volume 11(2), pp. 111-112, 1994.
Wesson DR, Ling W, Smith DE.
Zolpidem: An Addiction Medicine Perspective. California Society of Addiction
Medicine News, Spring, 1994.
Wesson DR, Smith DE & Ling W.
Prescription Drug Abuse and Addiction. Hazelden Educational Materials, Center
City, MN, 1994.
Smith DE & Seymour RB. LSD:
History and Toxicity. Psychiatric Annals, Volume 24(3), pp. 145-147, March,
1994.
Seymour RB, Smith DE & Ehrlich
P. Counseling the Adolescent Drug Abuse Client. Plenum Publishing Corporation,
New York, 1993.
Seymour RB & Smith DE. Crack
Cocaine: Prevention, Intervention & Spirituality. Treatment Centers Magazine,
1993.
Wesson DR, Smith DE & Seymour
RB. Sedative Hypnotics and Tricyclics. Synopsis of Substance Abuse. Williams and
Wilkins, Baltimore, 1993.
Wesson DR, Smith DE & Seymour
RB. Sedative-Hypnotics and Tricyclics. Clinical Handbook of Substance Abuse.
Williams and Wilkins, Baltimore, 1993.
Smith DE, Buxton ME, Bilal R &
Seymour RB. Cultural Points of Resistance to the Twelve Step Recovery Process.
Journal of Psychoactive Drugs, 1993.
Wesson DR, Ling W & Smith DE.
Prescription of Opioids for Treatment of Pain in Patients with Addictive
Disease. Journal of Pain and Symptom Management, Volume 8(5), pp. 289-296, July,
1993.
Smith DE, Wesson DR & Ling W.
Treatment of Multiple Drug/Alcohol Intoxication and Withdrawal. ASAM Principles
of Addiction, ASAM, 1993.
Wesson DR, Smith DE & Washburn
P. Medical Aspects of Chemical Dependency. Hazelden, 1993.
Seymour RB & Smith DE. The
Psychedelic Resurgence. Hazelden, 1993.
Morrison MA, Smith DE, Wilford
B, Ehrlich, P & Seymour RB. At War in the Fields of Play: Current Perspectives
on the Nature and Treatment of Adolescent Chemical Dependency. Journal of
Psychoactive Drugs, Volume 25(4), October-December, 1993.
Smith DE. Haight Ashbury
Revisited. Proceedings of the Hallucinogens, LSD and Raves Symposium, National
Press Club, November, 1993.
Smith DE & Seymour RB. Drugs
in the Workplace. Occupational Health and Safety, National Safety Council,
Itasca, Illinois, 1992.
Landry MJ, Smith DE, McDuff DR
& Baughman OL. Benzodiazepine Dependence and Withdrawal: Identification and
Medical Management. Journal of Family Practice, Volume 5(2), 1992.
Smith DE, Lusher T & Seymour
RB. Benzodiazepines and Other Sedative-Hypnotic Detoxification. Manual of the
Detoxification of the Pregnant Addict. Department of Health Services, State of
California, 1992.
Smith DE & Seymour RB.
Psychoactive Substance Use Disorders. Continuum Encyclopedia of Counseling,
Continuum Publishing Group, New York, 1991.
Smith DE & Seymour RB.
Benzodiazepines. Comprehensive Handbook of Drug and Alcohol Addiction, Marcel
Dekker, Inc., New York, 1991.
Seymour RB & Smith DE.
Hallucinogens. Comprehensive Handbook of Drug and Alcohol Addiction, Marcel
Dekker, Inc., New York, 1991.
Smith DE, Ehrlich P & Seymour
RB. Current Trends in Adolescent Drug Use. Psychiatric Annals, Volume 21(2),
1991.
Landry MJ, Smith DE, McDuff D,
et al. Anxiety and Substance Abuse Disorders: A Primer for Primary Care
Physicians. American Journal of Family Practice, Volume 4(1), pp. 447-456, July,
1991.
Landry M, Smith DE, McDuff D,
et al. Anxiety and Substance Abuse Disorders: The Treatment of High Risk
Patients. American Journal of Family Practice, Volume 4(1), pp. 447-456, July,
1991.
Smith DE & Seymour RB.
Psychoactive Substance Use Disorders. Continuum Encyclopedia of Counseling.
Continuum Publishing Group, New York, 1991.
Zweben JE, Smith DE & Stewart
P. Psychotic Conditions and Substance Abuse Use: Prescribing Guidelines and
Other Treatment Issues. Journal of Psychoactive Drugs, Volume 23(4), 1991.
Landry MJ, Smith DE &
Steinberg JR. Anxiety, Depression and Substance Abuse Disorders: Diagnosis,
Treatment and Prescribing Practices. Journal of Psychoactive Drugs, Volume
23(4), 1991.
Wesson DR, Smith DE & Seymour
RB. Sedative-Hypnotics and Tricyclics. Substance Abuse: A Comprehensive
Textbook. Williams and Wilkins, Baltimore, Maryland, 1991.
Smith DE. Addiction Medicine
and Primary Care. Western Journal of Medicine, May, 1990.
Smith DE & Wesson DR.
Prescription Drug Abuse: Patient, Physician and Cultural Responsibilities.
Western Journal of Medicine, Volume 152, pp. 613-616, May 1990.
Landry MJ & Smith DE.
Benzodiazepine Dependency Discontinuation: Focus on the Chemical Dependency
Detoxification Setting and Benzodiazepine Polydrug Abuse. Journal of
Psychoactive Drugs, Volume 24(2), pp. 145-156, 1990.
Seymour RB & Smith DE.
Identifying and Responding to Drug Abuse in the Workplace: An Overview. Journal
of Psychoactive Drugs, Volume 22(4), 1990.
Smith DE. The Addictive
Disease: Controversy and Understanding. Conference Address, 1989.
Smith DE & Seymour RB. The
Evolution of Drug Use: The Changing Street Drug Scene. California Pharmacist,
August, 1989.
Smith DE. From the 60’s to the
90’s: The Evolution of Chemical Dependency Treatment. The Counselor,
September-October, 1989.
Smith DE. Hazards of Cocaine
Becoming Notorious. U.S. Journal of Alcohol and Chemical Dependence, Volume
13(5), May, 1989.
Smith DE & Zweben, JE.
Considerations in Using Psychotropic Medicine with Dual Diagnosis Patients in
Recovery. Journal of Psychoactive Drugs, Volume 21(2), pp. 221-228, April-June,
1989.
Smith DE & Heilig S. Addiction
Medicine Alert. San Francisco Medicine, Volume 19, November, 1989.
Smith DE, Wesson DR, Camber S
& Landry MJ. Perceptions of Benzodiazepine and Cocaine Abuse by US Addiction
Specialists. National Directorate for Prevention of Alcohol and Drug Problems,
Volume 4, pp. 371-390, 1989.
Smith DE, Wesson DR & Landry
MJ. The Pharmacology of Benzodiazepine Addiction. Selective Therapeutic Index,
Volume 2(9), pp. 94-107, September, 1989.
Smith DE & Landry MJ. AIDS and
Chemical Dependency: An Overview. Journal of Psychoactive Drugs, Volume 20(2),
April-June, 1988.
Smith DE. Should the U.S.
Legalize Narcotics? U.S. Journal of Alcohol and Chemical Dependence, Volume
12(8), August, 1988.
Smith DE & Heilig S. Addiction
Update 1988: Treatable Diseases. San Francisco Medicine, Volume 32(2), August,
1988.
Landry MJ & Smith DE. AIDS and
Chemical Dependency: An Overview. Journal of Psychoactive Drugs, Volume 20(2),
pp. 141-147, 1988.
Smith DE, Wesson DR, Sees KL &
Morgan JP. An Epidemiological and Clinical Analysis of Propylhexedrine Abuse in
the United States. Journal of Psychoactive Drugs, Volume 20(4), pp. 441-442,
1988.
Smith DE & Wesson DR.
Substance Abuse in Industry: Identification, Intervention, Treatment and
Prevention, 1988.
Smith DE & Landry MJ.
Psychoactive Substance Use Disorders: Drugs and Alcohol. General Psychiatry,
Second Edition, pp. 266-285, 1988.
Smith DE & Seymour RB.
Clinical Issues on Drugs and the Law. Perspectives on Drug Abuse - Volume 1,
Freund Publishing House, Tel Aviv, 1988.
Monographs
Smith DE, Wesson DR, Steffens
S & Jue K. L-Tryptophan Treatment of Cocaine Dependency and the Eodinophilia
Myalgia Syndrome. Problems of Drug Dependence, NIDA Research Monograph #132,
Rockville, Maryland, 1992.
Smith DE & Wesson DR. Cocaine:
Treatment Perspectives. Cocaine Use in America: Epidemiological and Clinical
Perspectives, Institute on Drug Abuse Research Monograph Series 61, 1985.
Published Abstracts
Schermann, JM, Sandouk, P,
Redureau, M, Galons, H, Hiance, M, Kaplan, SA, Smith, DE. Inhibition of cocaine
brain uptake and facilitation of cocaine efflux from the brain by a systemic
specific antibody. Published abstract. College on Problems of Drug Dependence (CPDD),
61st Annual Scientific Meeting, June 12 – 17, 1999, Acapulco, Mexico.
SEQ 2_0 \* Arabic \r 22.
Kaplan, SA, Smith, DE, Markland, P, Perkins, BH, Ferrell, TM, Fulton, R,
Nettles, HS, Staas, JK, Tice, TR. In vivo confirmation of naltrexone sustained
release by microencapsulation in poly(D,L-lactide) for prolonged drug addiction
therapy. Published abstract. College on Problems of Drug Dependence (CPDD),
61st Annual Scientific Meeting, June 12 – 17, 1999, Acapulco, Mexico.
Books
Smith, DE & Seymour, RB.
Clinician’s Guide to Substance Abuse. McGraw-Hill Medical Publishing Division,
2001.
Wesson DR, Smith DE, Steffens
SC, Co-Editors. Crack and Ice: Treating Smokable Stimulant Abuse. Hazelden
Foundation, Center City, 1992.
Wesson DR & Smith DE. Treating
Opiate Dependency. Hazelden Foundation, Minneapolis, 1989.
Seymour RB, Smith DE, Inaba DE
& Landry MJ. The New Drugs: Look Alike Drugs, Drugs of Deception and Designer
Drugs. Hazelden Foundation, Center City, 1989.
Smith DE & Wesson DR. Treating
Cocaine Dependency. Hazelden Foundation, Minneapolis, 1988.
Seymour RB & Smith DE. The
Physician’s Guide to Psychoactive Drugs. The Haworth Press, New York, 1987.
Seymour RB & Smith DE. Guide
to Psychoactive Drugs: An Up to the Minute Reference to Mind Altering
Substances. Harrington Park Press, New York, 1987.
Seymour RB & Smith DE.
Drugfree: A Unique, Positive Approach to Staying off Alcohol and Other Drugs.
Facts on File Publications, New York, 1987.
Seymour RB & Smith DE. Still
Free After All These Years: Two Decades With The Haight Ashbury Free Medical
Clinic. Westwind Associates, Sausalito, 1987.
Smith DE, Gold MS, Olden K &
Dwyer BJ. Cocaine: Helping Patients Avoid the End of the Line. 1985.
Smith DE & Wesson DR. Treating
the Cocaine Abuser. Hazelden Foundation, 1985.
Smith DE, Co-Editor. The
Benzodiazepines: Current Standards for Medical Practice. MTP Press, Ltd.,
Boston, 1985.
Drug Abuse Films, Consultant
Haight Ashbury Heroin Film,
1999.
Haight Ashbury Video Series,
Cinemed, Inc., 1988.
The Haight Ashbury Cocaine
Film, Cinemed, Inc., 1985.
Uppers, Downers, All Arounders,
Cinemed Inc., 1984.
Through the Looking Glass,
Hazelden, 1984.
Film on the National
Commission on Marijuana and Drug Abuse Report, 1973.
